Camilla Muccini

20PUBLICATIONS
43CO-AUTHORS
Innate immunityRespiratory diseasesGene and molecular therapyPharmaceutical delivery technologiesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 28, 2026
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count Nadir.

Manuela Ceccarelli, Elena Delfina Ricci, Camilla Muccini

|Feb 20, 2026
Significant Impact of Previous Major Cardiovascular Events (MACEs) and Viremia on Risk of New MACEs in People Living with HIV on Antiretroviral Therapy.

Caterina Candela, Alessia Siribelli, Tommaso Clemente

|Jan 08, 2026
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine.

Gabriele Loi, Antonella Castagna, Camilla Muccini

|Dec 17, 2025
Routine HIV RNA Testing During Injectable Cabotegravir and Oral Preexposure Prophylaxis Use.

Angelo Roberto Raccagni, Riccardo Lolatto, Elena Bruzzesi

|Aug 28, 2025
Safety, Tolerability, and Metabolic Effects of Long-Acting Cabotegravir and Rilpivirine in HIV Care: A Comprehensive Review.

Martina Bottanelli, Antonella Castagna, Camilla Muccini

|Jul 30, 2025
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis.

Alessia Siribelli, Sara Diotallevi, Laura Galli

Pageof 4

Frequent Collaborators

5 joint publications

Tommaso Clemente

4 joint publications

Vincenzo Spagnuolo

4 joint publications

Silvia Nozza

2 joint publications

Angelo Roberto Raccagni